These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Discriminative stimulus properties of S(-)- and R(+)-cathinone, (+)-cathine and several structural modifications. Glennon RA; Schechter MD; Rosecrans JA Pharmacol Biochem Behav; 1984 Jul; 21(1):1-3. PubMed ID: 6463083 [TBL] [Abstract][Full Text] [Related]
5. Discriminative stimulus properties of (+)cathine, an alkaloid of the khat plant. Pehek EA; Schechter MD Pharmacol Biochem Behav; 1990 Jun; 36(2):267-71. PubMed ID: 2356199 [TBL] [Abstract][Full Text] [Related]
6. Phentermine+fenfluramine produce cocaine-like discriminative cues. Schechter MD; McBurney D Life Sci; 1996; 59(20):PL303-8. PubMed ID: 8890951 [TBL] [Abstract][Full Text] [Related]
7. Effects of (+)-fenfluramine on 3,4-methylenedioxymethamphetamine (MDMA) discrimination in rats. Baker LE; Makhay MM Pharmacol Biochem Behav; 1996 Feb; 53(2):455-61. PubMed ID: 8808158 [TBL] [Abstract][Full Text] [Related]
8. Effect of dopamine agonists and fenfluramine on discriminative behavior in obese and lean Zucker rats. Schechter MD; Finkelstein JA Pharmacol Biochem Behav; 1985 Jul; 23(1):7-11. PubMed ID: 4034621 [TBL] [Abstract][Full Text] [Related]
9. Discriminative stimulus properties of the atypical antipsychotic clozapine and the typical antipsychotic chlorpromazine in a three-choice drug discrimination procedure in rats. Porter JH; Prus AJ; Vann RE; Varvel SA Psychopharmacology (Berl); 2005 Feb; 178(1):67-77. PubMed ID: 15316715 [TBL] [Abstract][Full Text] [Related]
10. Norfenfluramine, the fenfluramine metabolite, provides stimulus control: evidence for serotonergic mediation. Boja JW; Schechter MD Pharmacol Biochem Behav; 1988 Oct; 31(2):305-11. PubMed ID: 3244707 [TBL] [Abstract][Full Text] [Related]
11. Discriminative stimulus properties of 1.25 and 5.0 mg/kg doses of clozapine in rats: examination of the role of dopamine, serotonin, and muscarinic receptor mechanisms. Prus AJ; Baker LE; Meltzer HY Pharmacol Biochem Behav; 2004 Feb; 77(2):199-208. PubMed ID: 14751446 [TBL] [Abstract][Full Text] [Related]
12. Temporal differences in behavioral effect of fenfluramine and norfenfluramine. Schechter MD Pharmacol Biochem Behav; 1990 Mar; 35(3):527-31. PubMed ID: 2339144 [TBL] [Abstract][Full Text] [Related]
13. Discriminative stimulus properties of the atypical antipsychotic drug clozapine in rats trained to discriminate 1.25 mg/kg clozapine vs. 5.0 mg/kg clozapine vs. vehicle. Prus AJ; Philibin SD; Pehrson AL; Porter JH Behav Pharmacol; 2006 Mar; 17(2):185-94. PubMed ID: 16495726 [TBL] [Abstract][Full Text] [Related]
14. Effect of fenfluramine and nicotine upon a stimulant-depressant continuum. Schechter MD Pharmacol Biochem Behav; 1981 Sep; 15(3):371-5. PubMed ID: 7291239 [TBL] [Abstract][Full Text] [Related]
15. Effect of altering dopamine or serotonin neurotransmitters upon cathinone discrimination. Schechter MD Pharmacol Biochem Behav; 1992 Jan; 41(1):37-41. PubMed ID: 1347176 [TBL] [Abstract][Full Text] [Related]
16. Cocaine discrimination is attenuated by isradipine and CGS 10746B. Schechter MD Pharmacol Biochem Behav; 1993 Mar; 44(3):661-4. PubMed ID: 8095726 [TBL] [Abstract][Full Text] [Related]
17. Involvement of 5-HT2C receptors in mediating the discriminative stimulus properties of m-chlorophenylpiperazine (mCPP). Callahan PM; Cunningham KA Eur J Pharmacol; 1994 May; 257(1-2):27-38. PubMed ID: 8082704 [TBL] [Abstract][Full Text] [Related]
18. Fenfluramine discrimination in obese and lean Zucker rats: serotonergic mediation of effect. Schechter MD Eur J Pharmacol; 1986 Jun; 125(1):135-41. PubMed ID: 3732388 [TBL] [Abstract][Full Text] [Related]
19. Discriminative stimulus effects of the NMDA receptor antagonists MK-801 and CGP 37849 in rats. Zajaczkowski W; Moryl E; Papp M Pharmacol Biochem Behav; 1996 Sep; 55(1):163-8. PubMed ID: 8870053 [TBL] [Abstract][Full Text] [Related]
20. Antagonism of the discriminative stimulus effects of cocaine at two training doses by dopamine D2-like receptor antagonists. Costanza RM; Barber DJ; Terry P Psychopharmacology (Berl); 2001 Nov; 158(2):146-53. PubMed ID: 11702088 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]